calendar
18,854 catalysts · 4,728 grant · 3,404 8k filing · 2,667 approval · 2,309 device 510k · 1,852 device recall · 1,612 device pma
next 91 dayslessmore
MonWedFri
18,854 catalysts · 4,728 grant · 3,404 8k filing · 2,667 approval · 2,309 device 510k · 1,852 device recall · 1,612 device pma
HL grant. $498,493. PI: AHAMED H IDRIS
DK grant. $556,876. PI: Benjamin Terry
DK grant. $786,876. PI: Anna H Grummon
HD grant. $467,474. PI: Ariel Salas
AI grant. $1,173,748. PI: Nippie Sarita Shah
AA grant. $248,990. PI: RUI ZHANG
DK grant. $161,664. PI: Polina Kukhareva
NS grant. $243,271. PI: AMINU ABDULLAHI TAURA
HL grant. $45,726. PI: Nicole L. Wolter
HL grant. $90,244. PI: Rupali Sood
CA grant. $1,977,698. PI: Petr Bruza
DA grant. $1,468,140
ES grant. $699,956. PI: Jennifer Lisa Ames
NS grant. $1,499,504. PI: Douglas M McCarty
CA grant. $400,000. PI: XUEDONG LIU
HL grant. $799,287. PI: Manhal Jaber Izzy
HL grant. $123,368. PI: Eun Kyung Lee
TR grant. $350,000. PI: Reza Shekarriz
AR grant. $45,173. PI: Jenny Nathans
DK grant. $54,538. PI: Alexander J Ledet
AG grant. $1,089,329. PI: Vipan Nikore
NS grant. $430,957. PI: Kerry Poppenberg
AG grant. $496,600. PI: Robert Johnston
DC grant. $80,395. PI: Claire Marie Dorey
GM grant. $2,250,542. PI: AMIN S GHABRIAL
DK grant. $1,778,953. PI: Peter A Crawford
MD grant. $50,897. PI: Sydney Yearley
MH grant. $49,538. PI: Paul J cavanah
AI grant. $446,875. PI: RONALD N HARTY
ES grant. $433,185. PI: David C Christiani
AA grant. $410,413. PI: DAVID HAROLD ZALD
HD grant. $276,979. PI: Arox Wadson Kamng'ona
ES grant. $200,680. PI: Mariah DeSerisy
AI grant. $583,468. PI: Mahmoud Salama Ahmed
NR grant. $383,159. PI: Laura Randa
HD grant. $691,294. PI: BRITTANY MARTIN
HL grant. $49,538. PI: Gloria Andreeva Stoyanova
TW grant. $124,524. PI: Alex Kayongo
AI grant. $49,538. PI: Grace Emily Van Susteren
Sponsor: PHARM ASSOC. Form: SOLUTION. Route: ORAL
Sponsor: PHARM ASSOC. Form: SOLUTION. Route: ORAL
Sponsor: AMGEN INC. Form: INJECTABLE. Route: INJECTION
Sponsor: YICHANG HUMANWELL. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: AMGEN INC. Form: INJECTABLE. Route: INJECTION
Chlorpromazine Hydrochloride Tablets, USP, 50 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi, India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534. NDC: 70710-1131-1 — Reason: CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit — Status: Ongoing
Chlorpromazine Hydrochloride Tablets, USP, 10 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi, India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534. NDC: 70710-1129-1 — Reason: CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit — Status: Ongoing
Chlorpromazine Hydrochloride Tablets, USP, 100 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi, India; Manufactured for: Northstar Rx LLC Memphis, TN 38141. NDC: 16714-050-01 — Reason: CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit — Status: Ongoing
Iodo Blanco Iodides, First Aid Antiseptic, Mercury Free, Iodine 2%, First Aid Antiseptic, Contains 1 fl. oz (30 ml) per bottle, Distributed by: Essential Products, www.essentialproductsusa.com, NDC: 70242-109-01 — Reason: Defective Container: broken or leaking bottles. — Status: Ongoing
Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension Rx Only, For Use in Ears Only, Manufactured By: Novartis Manufacturing NV, Belgium, Distributed by: Sandoz, Inc., Princeton, NJ, NDC# 0781-6186-67, Carton NDC# 0781-6186-67 — Reason: Temperature Abuse — Status: Ongoing
Chlorpromazine Hydrochloride Tablets, USP, 25 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi, India; Manufactured for: Northstar Rx LLC Memphis, TN 38141. NDC: 16714-048-01 — Reason: CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit — Status: Ongoing